Skip to main content
Mohamad Abou chakra on Muck Rack

Mohamad Abou chakra

As seen in: Taylor & Francis Online, Medical Xpress, UroToday, HOSPITALS Magazine, BJU International Journal

Get in touch with Mohamad

Contact Mohamad, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Impact of American Urological Association risk category on outcomes of intravesical BCG vs gemcitabine/docetaxel in high‐grade Ta non‐muscle‐invasive bladder cancer

|
By Mohamad Abou chakra, Ian M. McElree, Sarah Mott, Michael O'Donnell
| BJU International Journal Verified
Supporting Information Filename Description bju70149-sup-0001-TableS1.docxWord 2007 document , 15 KB Table S1. The AEs stratified by treatment group. References 1, , et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-a summary of the 2024 guidelines update. Eur Urol 2024; 86: 531–549 2, , et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline: 2024 amendment. J Urol 2024; 211: 533–538 3, , et al.
Open in Who Shared Issue with article?

Strategic sequencing of bladder-sparing therapies in the management of BCG-unresponsive non-muscle invasive bladder cancer

|
By Mohamad Abou chakra, Joost L. Boormans, Dickon Hayne, Michael A. O’Donnell
| Taylor & Francis Online
Intravesical Bacillus Calmette-Guérin (BCG) therapy remains the cornerstone of treatment for high-risk (HR) non-muscle-invasive bladder cancer (NMIBC), with maintenance regimens typically extending over 1 to 3 years to maximize therapeutic efficacy [Citation1,Citation2]. Nevertheless, approximately 40% of treated patients ultimately develop unresponsiveness to BCG [Citation3].
Open in Who Shared Issue with article?

Development of a prediction model for urinary tract infection risk after open reimplantation in children with primary unilateral vesicoureteral reflux: A multicentre study

|
By Mohamad Moussa, Bilal Aoun, Mohamad Abou chakra, Khadija Ismail
| BJU International Journal Verified
1 INTRODUCTION Vesicoureteral reflux (VUR) is a common congenital anomaly characterized by the backward flow of urine from the bladder into the ureters.1 It increases the risk of recurrent febrile urinary tract infections (UTIs), which may cause renal scarring, a major concern in children.2 Among children with febrile UTIs, renal scarring has been reported in up to 54% of those with VUR, compared to 12% in those without VUR.3, 4 Effective management of VUR is therefore considered important...
Open in Who Shared Issue with article?
See all 8 articles